Stryker vs. Johnson & Johnson vs. Zimmer Biomet: How they compare in Q1

Stryker, Johnson & Johnson and Zimmer Biomet all saw first-quarter revenue increases. The devicemakers also saw overall growth in their spine and orthopedic segments year over year.

Advertisement

Here is how their first-quarter performances compare:

Stryker

Total sales: $4.3 billion (+8.1 percent) 

Spine: $279 million (+0.1 percent)

Orthopedic: $1.9 billion (+8.1 percent)

Hips: $327 million (+5.9 percent)

Knees: $464 million (+12.5 percent)

 

Johnson & Johnson

Total sales: $23.4 billion (+5 percent)

Spine, sports and other: $712 million (+0.6 percent)

Orthopedic: $2.2 billion (+3.5 percent)

Hips: $389 million (+9.3 percent)

Knees: $339 million (+6.7 percent)

 

Zimmer Biomet

Total sales: $1.7 billion (+3.9 percent)

Hips: $451 million (+0.9 percent)

Knees: $662.8 million (+7.9 percent)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $416.8 million (-0.2 percent)

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.